IntelGenx Technologies Corp. IGX.TO Stock
IntelGenx Technologies Corp. Price Chart
IntelGenx Technologies Corp. IGX.TO Financial and Trading Overview
| IntelGenx Technologies Corp. stock price | 0.23 CAD |
| Previous Close | 0.27 CAD |
| Open | 0.28 CAD |
| Bid | 0.26 CAD x N/A |
| Ask | 0.28 CAD x N/A |
| Day's Range | 0.28 - 0.28 CAD |
| 52 Week Range | 0.15 - 0.35 CAD |
| Volume | 1K CAD |
| Avg. Volume | 33.89K CAD |
| Market Cap | 48.03M CAD |
| Beta (5Y Monthly) | 2.437676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.08 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IGX.TO Valuation Measures
| Enterprise Value | 57.45M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 54.888744 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 65.662 |
| Enterprise Value/EBITDA | -6.421 |
Trading Information
IntelGenx Technologies Corp. Stock Price History
| Beta (5Y Monthly) | 2.437676 |
| 52-Week Change | 12.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.35 CAD |
| 52 Week Low | 0.15 CAD |
| 50-Day Moving Average | 0.23 CAD |
| 200-Day Moving Average | 0.23 CAD |
IGX.TO Share Statistics
| Avg. Volume (3 month) | 33.89K CAD |
| Avg. Daily Volume (10-Days) | 16.81K CAD |
| Shares Outstanding | 174.65M |
| Float | 130.2M |
| Short Ratio | 4.28 |
| % Held by Insiders | 23.16% |
| % Held by Institutions | 0% |
| Shares Short | 154.78K |
| Short % of Float | 0.11% |
| Short % of Shares Outstanding | 0.090% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1111.086% |
| Gross Margin | -112.57% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.82% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 875K CAD |
| Revenue Per Share (ttm) | 0.005 CAD |
| Quarterly Revenue Growth (yoy) | -31.60% |
| Gross Profit (ttm) | -908000 CAD |
| EBITDA | -8948000 CAD |
| Net Income Avi to Common (ttm) | -10928000 CAD |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.84M CAD |
| Total Cash Per Share (mrq) | 0.02 CAD |
| Total Debt (mrq) | 14.14M CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.452 |
| Book Value Per Share (mrq) | -0.036 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9491000 CAD |
| Levered Free Cash Flow (ttm) | -6115625 CAD |
Profile of IntelGenx Technologies Corp.
| Country | Canada |
| State | QC |
| City | Montreal |
| Address | 6420 Abrams |
| ZIP | H4S 1Y2 |
| Phone | 514-331-7440 |
| Website | https://www.intelgenx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was incorporated in 1999 and is headquartered in Montreal, Canada.
Q&A For IntelGenx Technologies Corp. Stock
What is a current IGX.TO stock price?
IntelGenx Technologies Corp. IGX.TO stock price today per share is 0.23 CAD.
How to purchase IntelGenx Technologies Corp. stock?
You can buy IGX.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IntelGenx Technologies Corp.?
The stock symbol or ticker of IntelGenx Technologies Corp. is IGX.TO.
Which industry does the IntelGenx Technologies Corp. company belong to?
The IntelGenx Technologies Corp. industry is Biotechnology.
How many shares does IntelGenx Technologies Corp. have in circulation?
The max supply of IntelGenx Technologies Corp. shares is 192.4M.
What is IntelGenx Technologies Corp. Price to Earnings Ratio (PE Ratio)?
IntelGenx Technologies Corp. PE Ratio is now.
What was IntelGenx Technologies Corp. earnings per share over the trailing 12 months (TTM)?
IntelGenx Technologies Corp. EPS is -0.08 CAD over the trailing 12 months.
Which sector does the IntelGenx Technologies Corp. company belong to?
The IntelGenx Technologies Corp. sector is Healthcare.